Cargando…
β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
BACKGROUND: The possible association between β-adrenoceptor antagonists (β-blockers) and risk of COPD is controversial. The objective of the present study was to test whether β-blocker use is associated with susceptibility to the disease. METHODS: A total of 301,542 new users of β-blockers and 1,000...
Autores principales: | Nielsen, Anne Orholm, Pedersen, Lars, Sode, Birgitte Fischer, Dahl, Morten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537528/ https://www.ncbi.nlm.nih.gov/pubmed/31193622 http://dx.doi.org/10.1016/j.eclinm.2019.01.004 |
Ejemplares similares
-
Prediction of first cardiovascular disease event in 2.9 million individuals using Danish administrative healthcare data: a nationwide, registry-based derivation and validation study
por: Christensen, Daniel Mølager, et al.
Publicado: (2021) -
Danish Register of chronic obstructive pulmonary disease
por: Lange, Peter, et al.
Publicado: (2016) -
β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study
por: Meidahl Petersen, Kasper, et al.
Publicado: (2012) -
Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study
por: Sundbøll, Jens, et al.
Publicado: (2015) -
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)